Awareness

Etiam vitae dapibus rhoncus. Eget etiam aenean nisi montes felis pretium donec veni. Pede vidi condimentum et aenean

Awareness

Highlights Of International News

The African Union has called on the Nigerien army to “return to its barracks and restore constitutional authority within 15 days”, a few...

Awareness

German Justice: Iranian ‘Death Judge’ Unmasked

Last Friday, two limousines with tinted windows were parked in the parking lot of the INI (International Neuroscience Institute) mental hospital in Hanover....

Awareness

Cereals, arms and energy: the Russian presence in Africa

Grain exports, arms deliveries, energy cooperation: in recent years, Russia has strengthened its presence in Africa, an increasingly important market for the Russian...

Awareness

Niger EU Delegation: Recruitment 2023 – Admin Support

The European Union (EU) is the result of an economic and political partnership between 27 European countries. It plays a major role on...

Awareness

Burma Express: Weekly News Highlights (July 17-23)

Gavroche has selected for you some salient news in Burma during this past week. An essential news overview for anyone interested in this...

Awareness

North Korea Launches Cruise Missiles: Yellow Sea Alert

Pyongyang fired “several cruise missiles” into the Yellow Sea on Saturday, between the Korean peninsula and China, the Joint Chiefs of Staff in...

Awareness

Turkey’s EU Journey: Erdogan’s Second Miracle

we have hardly exaggerated – it is the Turkish President, Recep Tayyip Erdogan, by virtue of his ability to make a pact at...

Awareness

Influential Manipulation: Haiti’s People at Stake

In this weekly editorial from Haiti Observateur, reviewed by Rezo Nòdwès, the author raises concerns about relations between Haiti and foreign powers, in...

Awareness

Ecocide Penalized: A Victory For Nature

The Council of Ministers approved Thursday, in second reading, the bill reforming Book 2 of the Penal Code. Ecocide is one of the...

Awareness

CHMP Grants Favorable Opinion: Bristol Myers Melanoma

Bristol Myers Squibb announces that the European Medicines Agency’s CHMP has recommended approval of Opdivo as an adjuvant therapy for patients 12 years...